Aquinox(NLTX) - 2024 Q4 - Annual Results

V NEUROGENE This communication contains fowards-facking statements within the mecring of the Private Securities Lifiantion Reloam Act of 1995. These stolenents mov discuss and ex sults of operations or linancial condition, or otherwise, based on current expectations and belels of the management of Neurogene, as well as asumplions made by, and inform Newsocene, including, but not limited to stobernents recording the theropeulic podential and ulifies efficacy and clinical benefits of its programs, accluding i ...